Medication that lowers pressure in the eye reduces the risk of vision loss in glaucoma patients by 50 percent, new research finds.
Glaucoma is a leading cause of blindness. There is no cure for the disease and it is estimated that 120,000 people in the U.S. are blind because of it.
The main treatment for glaucoma is a class of drugs called prostaglandin analogues, which reduce pressure in the eye. They are usually administered through eye drops. These drugs were believed to slow vision loss in glaucoma patients, but this is the first research that quantifies the effectiveness of the treatment.
Doctors in the UK found that over the course of two years patients getting the drugs had 50 percent less risk of visual deterioration compared to those who used placebo drops.
© 2026 NewsmaxHealth. All rights reserved.